Home › Funds › Spruce Street Capital LP › ZLAB

Spruce Street Capital LP position in ZLAB

ZAI LAB LTD · Health Care

Spruce Street Capital LP reported holding 1,042,158 shares of ZLAB (ZAI LAB LTD) in its Q3 2026 13F filing — a position valued at US$27.5M, representing 4.36% of its reported portfolio and ranking #9 among its reported holdings. Spruce Street Capital LP has disclosed ZLAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.04M sh
Reported value held$27.45M
Portfolio Weight4.36%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ZLAB position evolved

Spruce Street Capital LP first disclosed a stake in ZLAB in Q2 2026 at 279,110 shares (US$5.3M). The position peaked in Q3 2026 at 1,042,158 shares, worth US$27.5M. Across 2 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,042,158 shares valued at US$27.5M — an increase of 763,048 shares quarter over quarter.. Notable position changes include a 273% increase in Q3 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 279.11K $5.30M New
Q3 2026 1.04M $27.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZLAB and 13F data

ZLAB (ZAI LAB LTD) is a Health Care company. 18 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZLAB

All ZLAB fund holders →

FAQ

How long has Spruce Street Capital LP held ZLAB?

Spruce Street Capital LP has disclosed ZLAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Spruce Street Capital LP's current position in ZLAB?

As of Q3 2026, Spruce Street Capital LP holds 1.04M shares of ZLAB (ZAI LAB LTD), valued at $27.45M, representing 4.36% of its reported portfolio and ranking #9.

Has Spruce Street Capital LP been buying or selling ZLAB?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP increased its position in ZLAB. The position peaked in Q3 2026 at 1.04M shares.

Which other funds hold ZLAB?

Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.